← Eichor
Condition: Neratinib Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Neratinib

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
EARLY_Phase 1 · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT06828588Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
Phase 1 · 3 location(s) · Fox Chase Cancer Center · NCT05274048Neratinib in Combination With Ruxolitinib in Patients With mTNBC
EARLY_Phase 1 · 1 location(s) · Baylor Research Institute · NCT06008275Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Chang
Phase 1 · 18 location(s) · National Cancer Institute (NCI) · NCT05372614Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual Disease
Phase 2 · 1 location(s) · University Health Network, Toronto · NCT05388149Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients
NA · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06892093Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and A
Phase 2 · 1 location(s) · University of Rochester · NCT04965064Adjuvant Trastuzumab Plus Neratinib in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Breas
Phase 3 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT05760612Adjuvant Therapy With Neratinib in HER2 Positive Early Breast Cancer
Phase N/A · 1 location(s) · Shu Wang · NCT06693024Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
Phase 2 · 5 location(s) · Vanderbilt-Ingram Cancer Center · NCT05919108Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (
Phase 2 · 188 location(s) · National Cancer Institute (NCI) · NCT06126276Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
Phase 2 · 4 location(s) · Ruth O'Regan · NCT04886531
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.